Found: 9
Select item for more details and to access through your institution.
Challenges and Opportunities in Accessing and Analysing FAERS Data: A Call Towards a Collaborative Approach.
- Published in:
- Drug Safety, 2023, v. 46, n. 10, p. 921, doi. 10.1007/s40264-023-01345-w
- By:
- Publication type:
- Article
Development of a Framework Structuring Themes in the Course of Adverse Drug Reactions from a Patient's Perspective.
- Published in:
- Drug Safety, 2023, v. 46, n. 10, p. 1039, doi. 10.1007/s40264-023-01343-y
- By:
- Publication type:
- Article
A Multi-method Exploratory Evaluation of a Service Designed to Improve Medication Safety for Patients with Monitored Dosage Systems Following Hospital Discharge.
- Published in:
- Drug Safety, 2023, v. 46, n. 10, p. 1021, doi. 10.1007/s40264-023-01342-z
- By:
- Publication type:
- Article
Duration of Effectiveness Evaluation of Additional Risk Minimisation Measures for Centrally Authorised Medicinal Products in the EU Between 2012 and 2021.
- Published in:
- Drug Safety, 2023, v. 46, n. 10, p. 1007, doi. 10.1007/s40264-023-01341-0
- By:
- Publication type:
- Article
Comparative Safety Surveillance of Triple (IDA) Versus Dual Therapy (DA) in Mass Drug Administration for Elimination of Lymphatic Filariasis in Kenya: A Cohort Event Monitoring Study.
- Published in:
- Drug Safety, 2023, v. 46, n. 10, p. 961, doi. 10.1007/s40264-023-01338-9
- By:
- Publication type:
- Article
Real-World Safety and Efficacy of Biosimilar CT-P13 in Patients with Immune-Mediated Inflammatory Diseases: Integrated Analysis of Three Japanese Prospective Observational Studies.
- Published in:
- Drug Safety, 2023, v. 46, n. 10, p. 991, doi. 10.1007/s40264-023-01340-1
- By:
- Publication type:
- Article
Automated Classification of Quality Defect Issues Relating to Substandard Medicines Using a Hybrid Machine Learning and Rule-Based Approach.
- Published in:
- Drug Safety, 2023, v. 46, n. 10, p. 975, doi. 10.1007/s40264-023-01339-8
- By:
- Publication type:
- Article
Real-World Safety and Effectiveness of Fluticasone Furoate/Vilanterol in Patients with Asthma and/or Chronic Obstructive Pulmonary Disease: A Post-Marketing Study in Korea.
- Published in:
- Drug Safety, 2023, v. 46, n. 10, p. 951, doi. 10.1007/s40264-023-01337-w
- By:
- Publication type:
- Article
Clinical Guidance on the Monitoring and Management of Trastuzumab Deruxtecan (T-DXd)-Related Adverse Events: Insights from an Asia-Pacific Multidisciplinary Panel.
- Published in:
- Drug Safety, 2023, v. 46, n. 10, p. 927, doi. 10.1007/s40264-023-01328-x
- By:
- Publication type:
- Article